ARCHIVES

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

This article is from The Cancer Letter archive.

Vol. 03 No. 26 | July 1, 1977

Download PDF Visit The Full Archive

Related Articles

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Group Urges U.S., USSR Exchange In Surgical Oncology

January 6, 1989

NCI Plans Two New RFAs For Stimulus Funds

March 6, 2009

Funding Opportunities

November 2, 2002

In Brief: Gregory Curt May Return As Director Of COP; Koop Locked In as Surgeon General Until Nov.

January 20, 1989